Lublin F - Search Results

1

Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note.

Wang G, Cutter GR, Cofield SS, Lublin F, Wolinsky JS, Gustafson T, Krieger S, Salter A. Wang G, et al. Among authors: lublin f. Mult Scler. 2017 Jun;23(7):982-987. doi: 10.1177/1352458516670733. Epub 2016 Sep 28. Mult Scler. 2017. PMID: 27682227 Free PMC article. Clinical Trial.

2

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Cutter GR, et al. Among authors: lublin f. Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871. Brain. 1999. PMID: 10355672

3

Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators.

Noseworthy JH, Wolinsky JS, Lublin FD, Whitaker JN, Linde A, Gjorstrup P, Sullivan HC. Noseworthy JH, et al. Among authors: lublin fd. Neurology. 2000 May 9;54(9):1726-33. doi: 10.1212/wnl.54.9.1726. Neurology. 2000. PMID: 10802775 Clinical Trial.

4

Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators.

Wolinsky JS, Narayana PA, Noseworthy JH, Lublin FD, Whitaker JN, Linde A, Gjörstrup P, Sullivan HC. Wolinsky JS, et al. Among authors: lublin fd. Neurology. 2000 May 9;54(9):1734-41. doi: 10.1212/wnl.54.9.1734. Neurology. 2000. PMID: 10802777 Clinical Trial.

5

Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis.

Whitaker JN, Wolinsky JS, Narayana PA, Bartolucci AA, Noseworthy JH, Lublin FD, Linde A, Gjörstrup P, Sullivan HC; North American Linomide Investigators. Whitaker JN, et al. Among authors: lublin fd. Arch Neurol. 2001 Jan;58(1):49-54. doi: 10.1001/archneur.58.1.49. Arch Neurol. 2001. PMID: 11176936

6

McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. McDonald WI, et al. Among authors: lublin fd. Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032. Ann Neurol. 2001. PMID: 11456302

7

Therapeutic approaches to secondary progressive multiple sclerosis.

Lublin FD. Lublin FD. Mult Scler. 2002 Feb;8(1):88-90. doi: 10.1177/135245850200800119. Mult Scler. 2002. PMID: 11936495 Review. No abstract available.

8

Effect of relapses on development of residual deficit in multiple sclerosis.

Lublin FD, Baier M, Cutter G. Lublin FD, et al. Neurology. 2003 Dec 9;61(11):1528-32. doi: 10.1212/01.wnl.0000096175.39831.21. Neurology. 2003. PMID: 14663037

9

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.

Petkau AJ, White RA, Ebers GC, Reder AT, Sibley WA, Lublin FD, Paty DW; IFNB Multiple Sclerosis Study Group. Petkau AJ, et al. Mult Scler. 2004 Apr;10(2):126-38. doi: 10.1191/1352458504ms1004oa. Mult Scler. 2004. PMID: 15124756

10

The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studies.

Cohen J, Cutter G, Lublin F, Schwid S. Cohen J, et al. Among authors: lublin f. Mult Scler. 2004 Jun;10(3):332-3. doi: 10.1191/1352458504ms1018xx. Mult Scler. 2004. PMID: 15222702 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page